What is Acrokeratosis Paraneoplastica?

Acrokeratosis paraneoplastica is also known as Bazex syndrome and is a rare paraneoplastic syndrome, a constellation of findings, which is due to the underlying presence of a systemic malignancy. It is important to take note of such conditions because a high index of suspicion is needed to make a diagnosis of the malignancy.

Clinical Features

It is a skin condition that consists of red scaly lesions over the extremities (the ears, nose, hands and feet), and is mostly associated with cancers of the upper airway or gastrointestinal tract. The lesions are present equally on both sides, and are not itchy in the majority of cases. Beginning at the very tips, they progress inwards and may finally involve the scalp, the legs or the arms, or the trunk. The patient usually gives a history of losing significant weight over the last year or so.

The typical patient is a white male who is over 40 years of age. In most cases various topical treatments are applied unsuccessfully. Treatment of the cancer often leads to partial resolution of skin symptoms as well. Early studies noted that a recurrence of the cancer was often heralded by the reappearance of previously healed skin lesions, underlining their paraneoplastic nature.

The nails are usually quickly involved, and become red and swollen, however, lacking any evidence of infection. Late involvement of the scalp may lead to a honeycomb appearance.

The skin lesions usually predate the clinical diagnosis of cancer by about 11 months on average. In about 60% of cases the cancer is a squamous cell carcinoma, of the head and neck, or the lungs. In 16% it is a poorly differentiated carcinoma, in about 8% an adenocarcinoma of the prostate, lung, stomach or esophagus, and very uncommonly it follows a small cell carcinoma of the lung, a bladder cancer, blood cancers or lymphoid malignancies, and cancers of the gall bladder, uterus or breast, among others.


It is not quite clear why skin lesions result from these cancers, but some think that the reaction is due to cross-reacting antibodies against the tumor, which bind to the keratinocytes or basement membrane of the skin, damaging it. Another theory is that the skin of such patients contains antigens resembling those in the tumor which stimulate the immune system. Others suggest that the tumor produces growth factors, molecules which stimulate the growth of the keratinocytes, such as transforming growth factor-1 or insulin growth factor-1, which cause the skin to become thickened and to peel.

Diagnosis and Management

The medical history should take note of risk factors for cancer such as smoking, alcohol and environmental toxins. Specific questioning will typically lead to the admission of fatigue, a feeling of not being well, and significant weight loss over the short term.

The early tests usually involve skin biopsy and direct immunofluorescence examination, which yield nonspecific results. If the lesions persist despite appropriate topical treatment, a full examination should be done, including required blood tests and imaging, to rule out internal malignancy. While the cancer is being treated, topical steroids and emollients may alleviate the skin scaling and reduce the lesion thickness. Some researchers have used vitamin A analogs or vitamin D derivatives, or calcipotriol, to help normalize epidermal growth along with definitive or palliative treatment of the tumor, depending on the stage of the cancer. In most cases, unfortunately, diagnosis is made after metastasis has already occurred, and the mortality is high in this condition due to the underlying cancer.

Further Reading

Last Updated: Feb 26, 2019

Dr. Liji Thomas

Written by

Dr. Liji Thomas

Dr. Liji Thomas is an OB-GYN, who graduated from the Government Medical College, University of Calicut, Kerala, in 2001. Liji practiced as a full-time consultant in obstetrics/gynecology in a private hospital for a few years following her graduation. She has counseled hundreds of patients facing issues from pregnancy-related problems and infertility, and has been in charge of over 2,000 deliveries, striving always to achieve a normal delivery rather than operative.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, Liji. (2019, February 26). What is Acrokeratosis Paraneoplastica?. News-Medical. Retrieved on July 21, 2024 from https://www.news-medical.net/health/What-is-Acrokeratosis-Paraneoplastica.aspx.

  • MLA

    Thomas, Liji. "What is Acrokeratosis Paraneoplastica?". News-Medical. 21 July 2024. <https://www.news-medical.net/health/What-is-Acrokeratosis-Paraneoplastica.aspx>.

  • Chicago

    Thomas, Liji. "What is Acrokeratosis Paraneoplastica?". News-Medical. https://www.news-medical.net/health/What-is-Acrokeratosis-Paraneoplastica.aspx. (accessed July 21, 2024).

  • Harvard

    Thomas, Liji. 2019. What is Acrokeratosis Paraneoplastica?. News-Medical, viewed 21 July 2024, https://www.news-medical.net/health/What-is-Acrokeratosis-Paraneoplastica.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.